Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

NOVOLIN GE NPH PENFILL

NOVO NORDISK CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is NOVOLIN GE NPH PENFILL discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that NOVOLIN GE NPH PENFILL 100UNIT has been permanently discontinued (last updated June 5, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is NOVOLIN GE NPH PENFILL not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file4 products
Affected strength100UNIT
Last updated2026-06-05

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

NOVOLIN GE NPH

NOVO NORDISK CANADA INC

100UNIT · DIN 02024225

Same strengthSame dosage formSame routeNo current shortage

HUMULIN N (CARTRIDGE)

ELI LILLY CANADA INC

100UNIT · DIN 01959239

Same strengthSame dosage formSame routeNo current shortage

NOVOLINSET GE NPH INJ SUS 100U/ML

NOVO NORDISK A/S

100UNIT · DIN 02024403

Same strengthSame dosage formSame routeNo current shortage

HUMULIN N (KWIKPEN)

ELI LILLY CANADA INC

100UNIT · DIN 02403447

Same strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02024268

Strength

100UNIT

Dosage Form

SUSPENSION

Route

SUBCUTANEOUS

Active Ingredient

INSULIN ISOPHANE HUMAN BIOSYNTHETIC

Tier

Unrated

Last Updated

2026-06-05

Reason for Shortage

Business reasons